Miriam Merad

Person

Cancer immunologist at Mount Sinai, New York

2 stories

Personalized Cancer Vaccine Shows Sustained Survival Benefit Six Years After Treatment

Cancer Researchers Report Encouraging Early Results for mRNA Vaccine Therapies